246 related articles for article (PubMed ID: 18938722)
1. [Ventricular arrhythmias of catecholaminergic origin and sudden death].
Jalife J
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-175-7. PubMed ID: 18938722
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
Cerrone M; Noujaim SF; Tolkacheva EG; Talkachou A; O'Connell R; Berenfeld O; Anumonwo J; Pandit SV; Vikstrom K; Napolitano C; Priori SG; Jalife J
Circ Res; 2007 Nov; 101(10):1039-48. PubMed ID: 17872467
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.
Iyer V; Hajjar RJ; Armoundas AA
Circ Res; 2007 Feb; 100(2):e22-31. PubMed ID: 17234962
[TBL] [Abstract][Full Text] [Related]
4. Common RyR2 variants associate with ventricular arrhythmias and sudden cardiac death in chronic heart failure.
Ran Y; Chen J; Li N; Zhang W; Feng L; Wang R; Hui R; Zhang S; Pu J
Clin Sci (Lond); 2010 Jun; 119(5):215-23. PubMed ID: 20408814
[TBL] [Abstract][Full Text] [Related]
5. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies.
George CH; Jundi H; Thomas NL; Fry DL; Lai FA
J Mol Cell Cardiol; 2007 Jan; 42(1):34-50. PubMed ID: 17081562
[TBL] [Abstract][Full Text] [Related]
6. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
Paavola J; Viitasalo M; Laitinen-Forsblom PJ; Pasternack M; Swan H; Tikkanen I; Toivonen L; Kontula K; Laine M
Eur Heart J; 2007 May; 28(9):1135-42. PubMed ID: 17347175
[TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor-targeted anti-arrhythmic therapy.
Wehrens XH; Lehnart SE; Marks AR
Ann N Y Acad Sci; 2005 Jun; 1047():366-75. PubMed ID: 16093511
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.
Jones PP; Jiang D; Bolstad J; Hunt DJ; Zhang L; Demaurex N; Chen SR
Biochem J; 2008 May; 412(1):171-8. PubMed ID: 18092949
[TBL] [Abstract][Full Text] [Related]
9. Role of catecholamine oxidation in sudden cardiac death.
Dhalla NS; Adameova A; Kaur M
Fundam Clin Pharmacol; 2010 Oct; 24(5):539-46. PubMed ID: 20584205
[TBL] [Abstract][Full Text] [Related]
10. [Genetic of catecholaminergic polymorphic ventricular tachycardia: basic concepts].
Medeiros-Domingo A
Arch Cardiol Mex; 2009 Dec; 79 Suppl 2():13-7. PubMed ID: 20361477
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
Swan H; Laitinen P; Kontula K; Toivonen L
J Cardiovasc Electrophysiol; 2005 Feb; 16(2):162-6. PubMed ID: 15720454
[TBL] [Abstract][Full Text] [Related]
12. Catecholaminergic polymorphic ventricular tachycardia.
Liu N; Colombi B; Raytcheva-Buono EV; Bloise R; Priori SG
Herz; 2007 May; 32(3):212-7. PubMed ID: 17497254
[TBL] [Abstract][Full Text] [Related]
13. Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.
Pizzale S; Gollob MH; Gow R; Birnie DH
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1319-21. PubMed ID: 18554199
[TBL] [Abstract][Full Text] [Related]
14. Acute isoproterenol leads to age-dependent arrhythmogenesis in guinea pigs.
Woulfe KC; Wilson CE; Nau S; Chau S; Phillips EK; Zang S; Tompkins C; Sucharov CC; Miyamoto SD; Stauffer BL
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1051-H1062. PubMed ID: 30028197
[TBL] [Abstract][Full Text] [Related]
15. Dispersions of repolarization and ventricular arrhythmogenesis: lessons from animal models.
Killeen MJ; Sabir IN; Grace AA; Huang CL
Prog Biophys Mol Biol; 2008; 98(2-3):219-29. PubMed ID: 19027779
[TBL] [Abstract][Full Text] [Related]
16. [Sudden death and cardiac insufficiency].
Geslin P
Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():9-14. PubMed ID: 8215794
[TBL] [Abstract][Full Text] [Related]
17. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
Milberg P; Pott C; Eckardt L; Breithardt G
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
[TBL] [Abstract][Full Text] [Related]
18. [Late ventricular potential as a risk factor for sudden cardiac death in chronically hemodialysed patients].
Wierzbicki P
Pol Merkur Lekarski; 1998 Nov; 5(29):310-2. PubMed ID: 10101510
[TBL] [Abstract][Full Text] [Related]
19. Sudden unexpected near death in epilepsy: malignant arrhythmia from a partial seizure.
Dupuis MJ; Evrard F; van Rijckevorsel K
Neurology; 2010 Jan; 74(2):181-2; author reply 182. PubMed ID: 20065256
[No Abstract] [Full Text] [Related]
20. The pathology of sudden cardiac death in patients with ischemic heart disease--arrhythmology for anatomic pathologists.
Saffitz JE
Cardiovasc Pathol; 2005; 14(4):195-203. PubMed ID: 16009318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
